News Room

  • March 15, 2017
    Altasciences Clinical Research Companies Recognized for Leadership
    Altasciences Clinical Research proudly announces that its companies, Algorithme Pharma and Vince & Associates Clinical Research, have each been awarded multiple 2017 CRO Leadership Awards.
  • January 11, 2017
    Vince & Associates Clinical Research, an Altasciences Company, Opens Vaping Room
    OVERLAND PARK, KS (January 11, 2017) – Vince & Associates Clinical Research, an Altasciences company, announced today the opening of a controlled ventilation indoor vaping room at their clinical research unit in Overland Park, Kansas.
  • December 5, 2016
    Altasciences Clinical Research Wins Best CRO Scrip Award
    Altasciences was selected from among many leading CROs by an expert Judging Panel, comprised of independent, senior industry experts from around the world, each chosen for their knowledge, objectivity and credibility.
  • August 15, 2016
    Altasciences CEO Named PharmaVOICE 100 Most Inspiring People in the Life-Sciences Industry
    LAVAL, QC, Canada (August 15, 2015) — Altasciences, one of the largest early phase clinical CROs in North America, is pleased to announce that Chris Perkin, CEO, has been named one of the 100 Most Inspiring People in the Life-Sciences Industry by PharmaVOICE magazine for the second time.
  • June 1, 2016
    Second iCardiac Certified Site for Altasciences Clinical Research
    LAVAL, QC, Canada (June 1, 2016) — Altasciences Clinical Research announced today that its clinical facility, Algorithme Pharma, in Montreal, Canada, has received its iCardiac Certification. In January 2015, Altasciences’ Overland Park site, Vince & Associates Clinical Research, became the first clinical research provider in the world to be iCardiac certified. High-precision technology is opening a new era where QT analysis can be conducted in earlier, first-in-human studies – before sponsors commit to further development work.